KarenQuillenMD
Hematology • Boston, MABlood Banking & Transfusion Medicine, Hematologic Oncology
Professor, Pathology & Laboratory Medicine, Boston University School of Medicine
Dr. Quillen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
670 Albany St
3rd Floor Room 310
Boston, MA 02118Phone+1 617-414-5314Fax+1 617-414-5315
Summary
- Dr. Karen Quillen is a hematologist in Boston, MA and is affiliated with Boston Medical Center. She received her medical degree from Queen's University at Kingston and has been in practice 26 years. She specializes in hematology and transfusion medicine.
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Brigham and Women's HospitalResidency, Internal Medicine, 1991 - 1994
Queen's University at KingstonClass of 1991
Certifications & Licensure
MA State Medical License 1997 - 2026
DC State Medical License 2007 - 2008- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- 2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis Start of enrollment: 2001 Aug 01
Publications & Presentations
PubMed
- 89 citationsLong-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.Vaishali Sanchorawala, Fangui Sun, Karen Quillen, J. Mark Sloan, John L. Berk
Blood. 2015-11-12 - 10 citationsNovel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute...Rachel Yuen, Dylan Steiner, Riley M.F. Pihl, Elizabeth Chavez, Alex Olson
Frontiers in Immunology. 2021-04-09 - 192 citationsOutcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.María Teresa Cibeira, Vaishali Sanchorawala, David C. Seldin, Karen Quillen, John L. Berk
Blood. 2011-10-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
